Dr Ivy Skincare achieves rapid sell-out following first retail partnership

Dr Ivy Skincare sold out of its initial stock less than a month after launching at John Bell & Croyden on 20 January, marking a strong start to the brand’s retail expansion.

Founded by Dr Ivona Igerc, the brand draws on more than 25 years of experience in aesthetic medicine, research and professional training.

The range is designed to bridge the gap between in-clinic procedures and at-home maintenance, offering patients medical-grade formulations to support and prolong treatment results.

Central to the portfolio is the Exosome Rejuvenation Home Kit, complemented by a line-up of LED and laser skincare devices. Core topical products include the Exosome Cleanser, Serum and Cream, all formulated to support skin regeneration and overall skin health.

The launch at John Bell & Croyden represents a significant step in the company’s bricks-and-mortar strategy, following its direct-to-consumer debut in April 2025.

The rapid sell-out suggests growing consumer demand for clinically backed skincare solutions positioned within a professional aesthetic framework.

The momentum also continues internationally, with Dr Ivy Skincare entering the Chinese market through a partnership with luxury retailer Lane Crawford.

The collaboration represents a significant milestone in the brand’s global growth strategy, accelerating its expansion into key international beauty markets.